These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11816823)

  • 1. Interstitial lung disease induced by exogenous agents: factors governing susceptibility.
    Nemery B; Bast A; Behr J; Borm PJ; Bourke SJ; Camus PH; De Vuyst P; Jansen HM; Kinnula VL; Lison D; Pelkonen O; Saltini C
    Eur Respir J Suppl; 2001 Sep; 32():30s-42s. PubMed ID: 11816823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffuse interstitial lung disorders caused by the environment and occupation].
    Nemery B
    Verh K Acad Geneeskd Belg; 2003; 65(6):367-80; discussion 381-4. PubMed ID: 14964037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related disparities: influence of environmental factors.
    Olden K; White SL
    Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual susceptibility to inhaled pollutants--identification, mechanisms and public health policy implications.
    Jedrychowski W; Maugeri U; Bianchi I
    G Ital Med Lav; 1996; 18(1-3):63-72. PubMed ID: 9287279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.
    Verleden GM; du Bois RM; Bouros D; Drent M; Millar A; Müller-Quernheim J; Semenzato G; Johnson S; Sourvino G; Olivier D; Pietinalho A; Xaubet A
    Eur Respir J Suppl; 2001 Sep; 32():17s-29s. PubMed ID: 11816821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers of host susceptibility to air pollutants in epidemiologic studies on chronic airways obstruction.
    Jedrychowski W; Maugeri U
    G Ital Med Lav; 1993; 15(5-6):153-8. PubMed ID: 7615176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD.
    Hukkanen J; Pelkonen O; Raunio H
    Eur Respir J Suppl; 2001 Sep; 32():122s-126s. PubMed ID: 11816819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
    Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
    Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-induced diffuse lung disease.
    Fontenot AP; Amicosante M
    Semin Respir Crit Care Med; 2008 Dec; 29(6):662-9. PubMed ID: 19221964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental triggers and susceptibility factors in idiopathic granulomatous diseases.
    Spagnolo P; Richeldi L; du Bois RM
    Semin Respir Crit Care Med; 2008 Dec; 29(6):610-9. PubMed ID: 19221959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New classifications and concepts of pathogenesis and management of diffuse interstitial lung diseases.
    Demedts M; Thomeer M
    Verh K Acad Geneeskd Belg; 2003; 65(6):337-50. PubMed ID: 14964035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle characteristics responsible for effects on human lung epithelial cells.
    Aust AE; Ball JC; Hu AA; Lighty JS; Smith KR; Straccia AM; Veranth JM; Young WC
    Res Rep Health Eff Inst; 2002 Dec; (110):1-65; discussion 67-76. PubMed ID: 12578113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine cell hyperplasia as an unusual form of interstitial lung disease.
    Reyes LJ; Majó J; Perich D; Morell F
    Respir Med; 2007 Aug; 101(8):1840-3. PubMed ID: 17586309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral-induced inflammation in interstitial lung diseases.
    Vassallo R
    Semin Respir Infect; 2003 Mar; 18(1):55-60. PubMed ID: 12652455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco smoke-related diffuse lung diseases.
    Vassallo R; Ryu JH
    Semin Respir Crit Care Med; 2008 Dec; 29(6):643-50. PubMed ID: 19221962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public knowledge regarding the role of genetic susceptibility to environmentally induced health conditions.
    Morris J; Gwinn M; Clyne M; Khoury MJ
    Community Genet; 2003; 6(1):22-8. PubMed ID: 12748435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interactions in chronic pulmonary diseases.
    Hirvonen A
    Mutat Res; 2009 Jul; 667(1-2):132-41. PubMed ID: 19563928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.